teleABLE to Reduce Post-Stroke Sedentary Behavior

Phase

N/A

Condition

Cerebral Ischemia

Stroke

Treatment

teleABLE (telehealth-delivered Activating Behavior for Lasting Engagement)

Health Education

Clinical Study ID

NCT06312709

STUDY00021288

K23HL159240

Ages > 18
All Genders

Study Summary

The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months.

Participants in this study will:

Complete questionnaires at Weeks 1, 8, and 24
Wear an activPAL monitor at Weeks 1, 8, and 24
Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions)
Complete an interview at Week 24

Eligibility Criteria

Inclusion

Inclusion Criteria:

Age: 18 years or older
Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment
≥6 hours of sedentary behavior on a typical weekday (Sedentary BehaviorQuestionnaire)
Able to walk 150 feet or more without physical assistance from another person, withor without assistive device (assessed by Functional Independence Measure, mobilityscore ≥5)
Able to access an electronic device (smartphone, tablet, or computer) that iscompatible with a videoconferencing application
Able to identify a support person with whom they have a face-to-face interaction atleast one time per week.
Able and willing to participate fully in the study and provide informed consent

Exclusion

Exclusion Criteria:

Currently receiving care in an inpatient rehabilitation, transitional care unit, orskilled nursing facility
Severe cognitive or communication impairments (inability to respond accurately tocomplete study telephone screening or complete informed consent)
Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis,amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease,Huntington's disease, glioblastoma)
Comorbid cancer, currently undergoing chemotherapy or radiation treatment
Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)
Received inpatient treatment or hospitalized for psychiatric condition and/oralcohol or substance abuse within the past 12 months
Diagnosis of a terminal illness and/or currently receiving hospice care
Currently pregnant or expecting to become pregnant in the next 6 months
History of skin sensitivity that precludes the use of medical tape necessary foradherence to activity monitor measure
Inability to speak, read, or understand English
Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)
Investigator discretion for safety or adherence reasons

Study Design